Last $0.70 USD
Change Today +0.009 / 1.30%
Volume 7.2K
BONE On Other Exchanges
Symbol
Exchange
NYSE Amex
As of 11:43 AM 07/10/14 All times are local (Market data is delayed by at least 15 minutes).

bacterin international holdi (BONE) Snapshot

Open
$0.70
Previous Close
$0.69
Day High
$0.70
Day Low
$0.70
52 Week High
03/20/14 - $1.41
52 Week Low
12/18/13 - $0.37
Market Cap
38.4M
Average Volume 10 Days
110.7K
EPS TTM
$-0.28
Shares Outstanding
55.0M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for BACTERIN INTERNATIONAL HOLDI (BONE)

Related News

No related news articles were found.

bacterin international holdi (BONE) Related Businessweek News

No Related Businessweek News Found

bacterin international holdi (BONE) Details

Bacterin International Holdings, Inc. develops, manufactures, and markets biologics products in the United States and internationally. The company’s Biologics Division offers products that are used in various applications, including enhancing fusion in spine surgery, relief of back pain with a facet joint stabilization, promotion of bone growth in foot and ankle surgery, promotion of skull healing, neurosurgery, and subchondral bone repair. Its biologics products include OsteoSponge, which provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSponge SC, a subchondral bone void filler; and OsteoWrap that wraps around non-union fractures to assist with fusion, as well as is used in conjunction with a hardware plate system. This segment also provides OsteoLock and BacFast facet stabilization dowels that are used to augment spinal procedures; and hMatrix dermal scaffold, which promotes cellular ingrowth, tissue vascularization, and regeneration. In addition, Biologics Division manufactures and sells sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled allografts; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. Bacterin International Holdings, Inc.’s Medical Devices division offers coatings for medical devices; OsteoSelect DBM putty, an osteoinductive and osteoconductive product used by surgeons as a bone void filler in the extremities and pelvis; and custom surgical instruments for use with allografts. This segment also sells Via and Elutia, surgical drain series products used to drain exudate from a surgical site. The company markets its products through direct sales, as well as through distributor relationships. Bacterin International Holdings, Inc. is headquartered in Belgrade, Montana.

128 Employees
Last Reported Date: 03/27/14
Founded in 2010

bacterin international holdi (BONE) Top Compensated Officers

Chief Executive Officer and Director
Total Annual Compensation: $143.1K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $422.3K
Chief Operating Officer
Total Annual Compensation: $338.6K
Vice President of Sales
Total Annual Compensation: $310.5K
Chief Scientific Officer
Total Annual Compensation: $271.1K
Compensation as of Fiscal Year 2013.

bacterin international holdi (BONE) Key Developments

Bacterin International Holdings, Inc. Announces the Appointment of Robert Di Silvio as President

Bacterin International Holdings, Inc. announced the addition of Robert (Bob) Di Silvio as President of the company. Mr. Di Silvio brings over 30 years' experience serving in executive management positions in the medical industry, overseeing sales and marketing efforts in the management of medical sales operations. Prior to joining Bacterin, Mr. Di Silvio served as Senior Vice President and General Manager of the Americas region for Lumenis since January 2012. As President of the Company, Mr. Di Silvio will be responsible for management of sales, marketing and business development.

Bacterin International Holdings, Inc. Presents at Newport Coast Securities 2014 National Sales & Equity Conference, Jun-13-2014 11:00 AM

Bacterin International Holdings, Inc. Presents at Newport Coast Securities 2014 National Sales & Equity Conference, Jun-13-2014 11:00 AM. Venue: The W Hotel, 541 Lexington Avenue, New York, New York, United States. Speakers: John P. Gandolfo, Chief Financial Officer, Principal Accounting Officer, Treasurer and Secretary.

Bacterin International Names Melanie Head as VP of Sales

Bacterin International Holdings, Inc. announced the addition of Melanie Head as Vice President of Sales. Prior to joining Bacterin, Head was the Vice President of Sales and Marketing for Lumenis, Inc.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BONE:US $0.70 USD +0.009

BONE Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Biolase Inc $1.94 USD -0.052
Cardica Inc $1.14 USD -0.02
Stereotaxis Inc $3.28 USD -0.01
Uroplasty Inc $2.68 USD +0.01
Vision Sciences Inc/DE $1.16 USD -0.03
View Industry Companies
 

Industry Analysis

BONE

Industry Average

Valuation BONE Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.1x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BACTERIN INTERNATIONAL HOLDI, please visit www.bacterin.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.